US2022195000A1PendingUtilityA1
Process for producing beta-lactoglobulin isolates and related methods and uses
Est. expiryJun 27, 2038(~11.9 yrs left)· nominal 20-yr term from priority
Inventors:Kasper Bøgelund LauridsenSøren Bang NielsenKåre SøndergaardGuilherme De Moura MacielHans BertelsenBehnaz Razi ParjikolaeiTanja Christine Jæger
A23J 1/205A23C 1/04A23B 70/30A23V 2002/00A23L 2/66A23L 33/19A23L 2/39A61K 9/0095A23J 3/08A23L 2/68A23L 2/102C07K 14/4717A23C 9/1427A23P 10/40A23L 2/60A61K 38/018A23L 33/135A23V 2300/34A23V 2300/10A23B 2/93
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention pertains to novel beta-lactoglobulin (BLG) isolates as well as to a method of producing such isolates and to uses of the powders, e.g. in beverage applications.
Claims
exact text as granted — not AI-modified1 .- 18 . (canceled)
19 . A beta-lactoglobulin (BLG) isolate powder, preferably prepared by spray-drying, having a pH in the range of 2.5-4.9 and comprising:
total protein in an amount of at least 30% w/w, BLG in an amount of at least 85% w/w relative to total protein water in an amount of at most 10% w/w, said BLG isolate powder having one or more of the following: a bulk density of at least 0.2 g/cm3, an intrinsic tryptophan fluorescence emission ratio (I330/I350) of at least 1.11, a degree of protein denaturation of at most 10%, a heat-stability at pH 3.9 of at most 200 NTU, and at most 15000 colony-forming units/g.
20 . The BLG isolate powder according to claim 19 , comprising total protein in an amount of at least 40% w/w, preferably at least 50% w/w, at least 60% w/w, more preferably at least 70% w/w, even more preferably at least 80% w/w, even more preferably at least 90% w/w, and most preferably at least 92% w/w.
21 . The BLG isolate powder according to claim 19 , comprising BLG in an amount of at least 88% w/w relative to total protein, preferably at least 90% w/w relative to total protein.
22 . The BLG isolate powder according to claim 19 , wherein the powder comprises lipid in an amount of at most 10% w/w, preferably at most 5% w/w, more preferably at most 2% w/w, and even more preferably at most 0.1% w/w.
23 . The BLG isolate powder according to claim 19 , having a bulk density of at least 0.20 g/cm3, preferably at least 0.30 g/cm3.
24 . The BLG isolate powder according to claim 19 , having an intrinsic tryptophan fluorescence emission ratio (I330/I350) of at least 1.11.
25 . The BLG isolate powder according to claim 19 , having a degree of protein denaturation of at most 10%.
26 . A liquid beta-lactoglobulin (BLG) isolate having a pH in the range of 2-4.9 and comprising:
total protein in an amount of at least 10% w/w, BLG in an amount of at least 85% w/w relative to total protein said BLG isolate powder having one or more of the following: an intrinsic tryptophan fluorescence emission ratio (I330/I350) of at least 1.11, a degree of protein denaturation of at most 10%, a heat-stability at pH 3.9 of at most 200 NTU, and at most 15000 colony-forming units/g, preferably at most 1000 colony-forming units/g.
27 . A method of producing a dried beta-lactoglobulin (BLG) isolate powder according to claim 19 containing BLG in an amount of at least 85% w/w relative to total protein, the method comprising the steps of:
a) providing a liquid BLG isolate having a pH in the range of 2-4.9, said liquid BLG isolate containing BLG in an amount of at least 85% w/w relative to total protein,
b) optionally, subjecting the liquid BLG isolate to a physical microbial reduction,
c) drying the liquid BLG isolate by spray-drying.
28 . The method according to claim 27 , wherein the liquid BLG isolate comprises a total solids content in an amount in the range of 5-50% w/w.
29 . The method according to claim 27 , wherein the protein fraction of the liquid BLG isolate has an intrinsic tryptophan fluorescence emission ratio (I330/I350) of at least 1.11.
30 . The method according to claim 27 , wherein the protein of liquid BLG isolate has a degree of protein denaturation of at most 10% w/w.
31 . The method according to claim 27 , wherein the provision of the liquid BLG isolate involves isolating BLG from whey protein feed, and optionally subjecting the resulting BLG-enriched composition to one or more steps selected from the group of:
demineralisation, addition of minerals, dilution, physical microbial reduction, concentration, and pH-adjustment.
32 . The method according to claim 27 , wherein the liquid BLG isolate is subjected to physical microbial reduction, which preferably involves or even consists of heat-treatment.
33 . The method according to claim 27 , wherein the liquid BLG isolate is a liquid BLG isolate according to claim 8 .
34 . Use of the BLG isolate powder according to claim 19 or the liquid BLG isolate according to claim 26 as an ingredient for the production of a food product, e.g. a beverage or an instant beverage powder, having a pH in the range of 2-4.7 and furthermore having one or more of the following:
a reduced level of drying mouthfeel,
improved transparency, and/or
increased content of protein, preferably heat-treated beverages containing a protein content in an amount of at least 3-45% w/w, more preferably 11-40% w/w, even more preferably 15-38% w/w and most preferably 20-36% w/w.Join the waitlist — get patent alerts
Track US2022195000A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.